About ABL Diagnostics
ABL Diagnostics is a company based in Woippy (France) founded in 2015.. The company has 19 employees as of December 31, 2024. ABL Diagnostics offers products and services including DeepChek® Assay, UltraGene Assay, and Nadis®. ABL Diagnostics operates in a competitive market with competitors including Souzhou Ribo Life Science, Altis Biosystems, Senzo, PathoQuest and Hememics Biotechnologies, among others.
- Headquarter Woippy, France
- Employees 19 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Abl Diagnostics Sa
-
Annual Revenue
$5.54 M (USD)-5.03as on Dec 31, 2024
-
Net Profit
$296.26 K (USD)424.58as on Dec 31, 2024
-
EBITDA
$328.3 K (USD)594as on Dec 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
19
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of ABL Diagnostics
ABL Diagnostics is a publicly listed company on the EURONEXT with ticker symbol ABLD in France, operating in the Finance sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of ABL Diagnostics
ABL Diagnostics offers a comprehensive portfolio of products and services, including DeepChek® Assay, UltraGene Assay, and Nadis®. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Tool for whole genome HIV-1 genotyping through sequencing.
Detects SARS-CoV-2 and other viruses via real-time PCR.
Electronic medical record system for lab automation.
Funding Insights of ABL Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by ABL Diagnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ABL Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Abl Diagnostics Comparisons
Competitors of ABL Diagnostics
ABL Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Souzhou Ribo Life Science, Altis Biosystems, Senzo, PathoQuest and Hememics Biotechnologies, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Nucleic acid drugs are developed via RNA interference technology.
|
|
| domain | founded_year | HQ Location |
Provider of invitro platform for drug testing
|
|
| domain | founded_year | HQ Location |
Point-of-care diagnostic devices for infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Next-generation sequencing is provided for microbiology testing applications.
|
|
| domain | founded_year | HQ Location |
Biopreservation platform for mammalian cells and biologics is developed.
|
|
| domain | founded_year | HQ Location |
Provide tools that accelerate new strategies for the diagnosis and treatment of inherited disorders, cancer, and infectious disease.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Abl Diagnostics
Frequently Asked Questions about ABL Diagnostics
When was ABL Diagnostics founded?
ABL Diagnostics was founded in 2015.
Where is ABL Diagnostics located?
ABL Diagnostics is headquartered in Woippy, France. It is registered at Woippy, Grand Est, France.
Who is the current CEO of ABL Diagnostics?
Ronan Boulme is the current CEO of ABL Diagnostics.
How many employees does ABL Diagnostics have?
As of Dec 31, 2024, the latest employee count at ABL Diagnostics is 19.
What is the annual revenue of ABL Diagnostics?
Annual revenue of ABL Diagnostics is $5.54M as on Dec 31, 2024.
What does ABL Diagnostics do?
ABL Diagnostics was founded in 2015 in Woippy, France, within the biotechnology sector focused on infectious disease diagnostics. Molecular biology assays and kits, including UltraGene for detection and DeepChek for genotyping via DNA sequencing, are provided to microbiology laboratories. Real-time PCR assays, instruments, consumables, and downstream analysis software are also supplied to support diagnostic operations across Europe.
Who are the top competitors of ABL Diagnostics?
ABL Diagnostics's top competitors include Altis Biosystems, Souzhou Ribo Life Science and Quantalife.
What products or services does ABL Diagnostics offer?
ABL Diagnostics offers DeepChek® Assay, UltraGene Assay, and Nadis®.
Is ABL Diagnostics publicly traded?
Yes, ABL Diagnostics is publicly traded on EURONEXT under the ticker symbol ABLD.
What is ABL Diagnostics's ticker symbol?
The ticker symbol of ABL Diagnostics is ABLD on EURONEXT.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.